Colestipol Hydrochloride NDC 59762-0260

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-0260Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-0260Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59762-0260-1	59762026001	30 PACKET in 1 CARTON (59762-0260-1) / 5 g in 1 PACKETMarketed from Apr 4, 1977
59762-0260-2	59762026002	90 PACKET in 1 CARTON (59762-0260-2) / 5 g in 1 PACKETMarketed from Apr 4, 1977
59762-0260-3	59762026003	500 g in 1 BOTTLE (59762-0260-3)Marketed from Apr 4, 1977

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Colestipol Hydrochloride
Generic name (nonproprietary): colestipol hydrochloride
Active ingredients: Colestipol hydrochloride — 5 g/5g
Dosage form: Granule, For suspension
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 017563
Marketing start: Apr 4, 1977
Listing expires: Dec 31, 2026
Other FDA classes: Bile-acid Binding Activity (Mechanism)
Identifiers: Product ID 59762-0260_a0444824-730e-4e63-9ddf-54461b1c4900SPL ID a0444824-730e-4e63-9ddf-54461b1c4900SPL set ID 4e89bf6e-c78a-402e-9cb2-8d02f6047d68RxCUI 1048450UNII X7D10K905G
Pharmacologic class: Bile Acid Sequestrant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459762026001 followed by a unit qualifier and the quantity

Package 59762-0260-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 7, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Since no drug is innocuous, strict attention should be paid to the indications and contraindications, particularly when selecting drugs for chronic long-term use. Colestipol hydrochloride granules are indicated as adjunctive therapy to diet for the reduction of elevated serum total and low-density lipoprotein (LDL) cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins [LDL] cholesterol) who do not respond adequately to diet. Generally, colestipol hydrochloride granules have no clinically significant effect on serum triglycerides, but with its use triglyceride levels may be raised in some patients. Therapy with lipid-altering agents…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)